InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: GS1 post# 110856

Sunday, 01/11/2015 7:32:32 AM

Sunday, January 11, 2015 7:32:32 AM

Post# of 130503
Avanir is having success with the LID drug (company just got acquired by Otsuka). But just know their is competition out there in the LID market (just keeping things straight here).

Also, AMBS is presenting the LymPro data at the Biotech Showcase Conference(and not at the JPM Morgan conference).